{"entities": [{"EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "TradingSymbol": "CCEL", "EntityCentralIndexKey": "862692", "db": 1, "Industry_SEC": "Services-Misc Health & Allied Services, Nec", "Industry_SEC_db": 8090, "Industry": "Health Care", "Industry_db": 9, "Region": "Florida", "Region_db": 10, "SecurityExchangeName": "0", "SECurl": "0", "URL": "", "SEC_Update": "2021-11-11", "SEC_UpdateDateAndTime": null, "SecuritiesUpdate": "2021-06-02T00:00:00Z", "OpinionLastYear": null, "OpinionSecondLastYear": null, "OpinionThirdLastYear": null, "OpinionFourthLastYear": null, "ClockLastYear": 309.0, "ClockSecondLastYear": 313.0, "ClockThirdLastYear": 291.0, "ClockFourthLastYear": 89.0, "BridgeLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeSecondLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeThirdLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeFourthLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "Anomalies": "0", "AnomaliesRatio1": 33.57, "AnomaliesRatio2": 96.18, "AnomaliesRatio3": 100.15, "AnomaliesRatio4": 7.44, "AnomaliesRatio5": 82.59, "AnomaliesRatio6": 59.09, "NumberOfYearsAudited": 0, "CommonSharesIntrinsicValueLastYear": 202620859, "CommonSharesIntrinsicValueSecondLastYear": 178298587, "CommonSharesIntrinsicValueThirdLastYear": 166280736, "CommonSharesIntrinsicValueFourthLastYear": 50951589, "MarketCapitalizationLastYear": 65488397, "MarketCapitalizationSecondLastYear": 56969378, "MarketCapitalizationThirdLastYear": 57120398, "MarketCapitalizationFourthLastYear": 57267839, "CommonShareIntrinsicValueLastYear": 26.76, "CommonShareIntrinsicValueSecondLastYear": 23.63, "CommonShareIntrinsicValueThirdLastYear": 21.31, "CommonShareIntrinsicValueFourthLastYear": 7.17, "CommonSharePriceLastYear": 8.65, "CommonSharePriceSecondLastYear": 7.55, "CommonSharePriceThirdLastYear": 7.32, "CommonSharePriceFourthLastYear": 8.06, "CommonSharesOutstandingLastYear": 7570913, "CommonSharesOutstandingSecondLastYear": 7545613, "CommonSharesOutstandingThirdLastYear": 7803333, "CommonSharesOutstandingFourthLastYear": 7105191, "month_end": 11, "lastyear": "2020-11-30", "secondlastyear": "2019-11-30", "thirdlastyear": "2018-11-30", "fourthlastyear": "2017-11-30", "fifthlastyear": "2016-11-30", "sixthlastyear": "2015-11-30", "amendlastyear": "", "amendsecondlastyear": "", "amendthirdlastyear": "", "amendfourthlastyear": "", "amendfifthlastyear": "", "amendsixthlastyear": "", "accessionnumberlastyear": "0001564590-21-009945", "accessionnumbersecondlastyear": "0001193125-20-056695", "accessionnumberthirdlastyear": "0001193125-19-057945", "accessionnumberfourthlastyear": "0001193125-18-064199", "accessionnumberfifthlastyear": "0001193125-17-062739", "accessionnumbersixthlastyear": "0001193125-16-485790", "urlbalancesheetlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000156459021009945/R2.htm", "urlbalancesheetsecondlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312520056695/R2.htm", "urlbalancesheetthirdlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312519057945/R2.htm", "urlbalancesheetfourthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312518064199/R2.htm", "urlbalancesheetfifthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312517062739/R2.htm", "urlbalancesheetsixthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312516485790/R2.htm", "urlincomestatementlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000156459021009945/R4.htm", "urlincomestatementsecondlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312520056695/R4.htm", "urlincomestatementthirdlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312519057945/R4.htm", "urlincomestatementfourthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312518064199/R4.htm", "urlincomestatementfifthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312517062739/R4.htm", "urlincomestatementsixthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312516485790/R4.htm", "urlcomprehensiveincomelastyear": "", "urlcomprehensiveincomesecondlastyear": "", "urlcomprehensiveincomethirdlastyear": "", "urlcomprehensiveincomefourthlastyear": "", "urlcomprehensiveincomefifthlastyear": "", "urlcomprehensiveincomesixthlastyear": "", "urlshareholdersequitylastyear": "", "urlshareholdersequitysecondlastyear": "", "urlshareholdersequitythirdlastyear": "", "urlshareholdersequityfourthlastyear": "", "urlshareholdersequityfifthlastyear": "", "urlshareholdersequitysixthlastyear": "", "urlcashflowlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000156459021009945/R5.htm", "urlcashflowsecondlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312520056695/R5.htm", "urlcashflowthirdlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312519057945/R5.htm", "urlcashflowfourthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312518064199/R5.htm", "urlcashflowfifthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312517062739/R5.htm", "urlcashflowsixthlastyear": "https://www.sec.gov/Archives/edgar/data/862692/000119312516485790/R5.htm", "ad1.db": 0, "ad1.AccessionNumber": "0001564590-21-009945", "ad1.AmendmentFlag": "", "ad1.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "ad1.Period": "lastyear", "ad1.PeriodEndDate": "2020-11-30", "ad1.TradingSymbol": "CCEL", "ad1.CurrentAssets": 18556202, "ad1.NonCurrentAssets": 27643892, "ad1.Assets": 0, "ad1.CurrentLiabilities": -16414621, "ad1.NonCurrentLiabilities": -33349240, "ad1.Liabilities": 0, "ad1.ShareholdersEquity": 2665135, "ad1.LiabilitiesAndShareholdersEquity": 0, "ad1.CurrentAssetsGL_i": "", "ad1.CurrentAssetsGL_ii": "", "ad1.CurrentAssetsGL_iii": "", "ad1.AnomalyCurrentAssets": 0, "ad1.AnomalyCurrentAssetsSEC": 0, "ad1.NonCurrentAssetsGL_i": "", "ad1.NonCurrentAssetsGL_ii": "", "ad1.NonCurrentAssetsGL_iii": "", "ad1.AnomalyNonCurrentAssets": -11064034, "ad1.AnomalyNonCurrentAssetsSEC": 0, "ad1.AnomalyAssets": 0, "ad1.CurrentLiabilitiesGL_i": "", "ad1.CurrentLiabilitiesGL_ii": "", "ad1.CurrentLiabilitiesGL_iii": "", "ad1.AnomalyCurrentLiabilities": 0, "ad1.AnomalyCurrentLiabilitiesSEC": 0, "ad1.NonCurrentLiabilitiesGL_i": "", "ad1.NonCurrentLiabilitiesGL_ii": "", "ad1.NonCurrentLiabilitiesGL_iii": "", "ad1.AnomalyNonCurrentLiabilities": -1797264, "ad1.AnomalyNonCurrentLiabilitiesSEC": 0, "ad1.AnomalyLiabilities": 0, "ad1.AnomalyShareholdersEquity": 0, "ad1.ShareholdersEquityBalanceGL_i": "", "ad1.ShareholdersEquityBalanceGL_ii": "", "ad1.ShareholdersEquityBalanceGL_iii": "", "ad1.AnomalyShareholdersEquitySEC": 0, "ad1.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad1.Sales": 0, "ad1.CostOfSales": 0, "ad1.GrossMargin": 9413255, "ad1.OperatingExpenses": 0, "ad1.OperatingIncome": -7661597, "ad1.IncomeBeforeTaxes": -5039323, "ad1.NetIncome": -3624596, "ad1.NetIncomeAttributableToNonControllingInterest": 0, "ad1.GrossMarginGL_i": "", "ad1.GrossMarginGL_ii": "", "ad1.GrossMarginGL_iii": "", "ad1.AnomalyGrossMargin": 0, "ad1.OperatingExpensesGL_i": "", "ad1.OperatingExpensesGL_ii": "", "ad1.OperatingExpensesGL_iii": "", "ad1.AnomalyOperatingExpenses": 0, "ad1.OperatingIncomeGL_i": "", "ad1.OperatingIncomeGL_ii": "", "ad1.OperatingIncomeGL_iii": "", "ad1.AnomalyOperatingIncome": 0, "ad1.IncomeBeforeTaxesGL_i": "", "ad1.IncomeBeforeTaxesGL_ii": "", "ad1.IncomeBeforeTaxesGL_iii": "", "ad1.AnomalyIncomeBeforeTaxes": 0, "ad1.NetIncomeGL_i": "", "ad1.NetIncomeGL_ii": "", "ad1.NetIncomeGL_iii": "", "ad1.AnomalyNetIncome": 0, "ad1.OtherComprehensiveIncome": 0, "ad1.ComprehensiveIncome": 0, "ad1.OtherComprehensiveIncomeGL_i": "", "ad1.OtherComprehensiveIncomeGL_ii": "", "ad1.OtherComprehensiveIncomeGL_iii": "", "ad1.AnomalyOtherComprehensiveIncome": -3624596, "ad1.AnomalyComprehensiveIncome": 0, "ad1.ShareholdersEquityBeginning": 0, "ad1.ConvertibleDebt": 0, "ad1.CommonShares": 0, "ad1.PreferredShares": 0, "ad1.RetainedEarnings": 0, "ad1.AccumulatedOtherComprehensiveIncome": 0, "ad1.TreasuryShares": 0, "ad1.EmployeeBenefitTrust": 0, "ad1.NonControllingInterests": 0, "ad1.AnomalyConvertibleDebt": 0, "ad1.AnomalyCommonShares": 587391, "ad1.AnomalyPreferredShares": 0, "ad1.AnomalyRetainedEarnings": 0, "ad1.AnomalyAccumulatedOtherComprehensiveIncome": 3624596, "ad1.AnomalyTreasuryShares": 0, "ad1.AnomalyEmployeeBenefitTrust": 0, "ad1.AnomalyNonControllingInterests": 0, "ad1.ShareholdersEquityGL_i": "", "ad1.ShareholdersEquityGL_ii": "", "ad1.ShareholdersEquityGL_iii": "", "ad1.OperatingActivities": 0, "ad1.InvestingActivities": 0, "ad1.FinancingActivities": 0, "ad1.IncreaseDecreaseInCash": 0, "ad1.CashFlowCashExplainedDifference": 0, "ad1.OperatingActivitiesGL_i": "", "ad1.OperatingActivitiesGL_ii": "", "ad1.OperatingActivitiesGL_iii": "", "ad1.AnomalyOperatingActivities": 0, "ad1.AnomalyOperatingActivitiesSEC": 0, "ad1.InvestingActivitiesGL_i": "", "ad1.InvestingActivitiesGL_ii": "", "ad1.InvestingActivitiesGL_iii": "", "ad1.AnomalyInvestingActivities": 350000, "ad1.AnomalyInvestingActivitiesSEC": 0, "ad1.FinancingActivitiesGL_i": "", "ad1.FinancingActivitiesGL_ii": "", "ad1.FinancingActivitiesGL_iii": "", "ad1.AnomalyFinancingActivities": 1945000, "ad1.AnomalyFinancingActivitiesSEC": 0, "ad1.TargetWorkingCapital": 1.2, "ad1.ReinvestmentOfMaintenance": 99962, "ad1.NormalizedDividendPaymentToNonControllingInterests": 0, "ad1.NormalizedDividendPaymentToPreferredShareholders": 0, "ad1.TheoricalInterestRate": 0.035, "ad1.TheoricalTaxRate": 0.2807375117649732, "ad1.CapitalizationRateFloor": 0.021, "ad2.db": 0, "ad2.AccessionNumber": "0001193125-20-056695", "ad2.AmendmentFlag": "", "ad2.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "ad2.Period": "secondlastyear", "ad2.PeriodEndDate": "2019-11-30", "ad2.TradingSymbol": "CCEL", "ad2.CurrentAssets": 15387611, "ad2.NonCurrentAssets": 27498549, "ad2.Assets": 0, "ad2.CurrentLiabilities": -15429429, "ad2.NonCurrentLiabilities": -35834582, "ad2.Liabilities": 0, "ad2.ShareholdersEquity": 6952851, "ad2.LiabilitiesAndShareholdersEquity": 0, "ad2.CurrentAssetsGL_i": "", "ad2.CurrentAssetsGL_ii": "", "ad2.CurrentAssetsGL_iii": "", "ad2.AnomalyCurrentAssets": 0, "ad2.AnomalyCurrentAssetsSEC": 0, "ad2.NonCurrentAssetsGL_i": "", "ad2.NonCurrentAssetsGL_ii": "", "ad2.NonCurrentAssetsGL_iii": "", "ad2.AnomalyNonCurrentAssets": -12646000, "ad2.AnomalyNonCurrentAssetsSEC": 0, "ad2.AnomalyAssets": 0, "ad2.CurrentLiabilitiesGL_i": "", "ad2.CurrentLiabilitiesGL_ii": "", "ad2.CurrentLiabilitiesGL_iii": "", "ad2.AnomalyCurrentLiabilities": 0, "ad2.AnomalyCurrentLiabilitiesSEC": 0, "ad2.NonCurrentLiabilitiesGL_i": "", "ad2.NonCurrentLiabilitiesGL_ii": "", "ad2.NonCurrentLiabilitiesGL_iii": "", "ad2.AnomalyNonCurrentLiabilities": -2850000, "ad2.AnomalyNonCurrentLiabilitiesSEC": 0, "ad2.AnomalyLiabilities": 0, "ad2.AnomalyShareholdersEquity": 0, "ad2.ShareholdersEquityBalanceGL_i": "", "ad2.ShareholdersEquityBalanceGL_ii": "", "ad2.ShareholdersEquityBalanceGL_iii": "", "ad2.AnomalyShareholdersEquitySEC": 0, "ad2.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad2.Sales": 0, "ad2.CostOfSales": 0, "ad2.GrossMargin": 9863780, "ad2.OperatingExpenses": 0, "ad2.OperatingIncome": -5062706, "ad2.IncomeBeforeTaxes": -3391415, "ad2.NetIncome": -2290774, "ad2.NetIncomeAttributableToNonControllingInterest": 0, "ad2.GrossMarginGL_i": "", "ad2.GrossMarginGL_ii": "", "ad2.GrossMarginGL_iii": "", "ad2.AnomalyGrossMargin": 0, "ad2.OperatingExpensesGL_i": "", "ad2.OperatingExpensesGL_ii": "", "ad2.OperatingExpensesGL_iii": "", "ad2.AnomalyOperatingExpenses": 0, "ad2.OperatingIncomeGL_i": "", "ad2.OperatingIncomeGL_ii": "", "ad2.OperatingIncomeGL_iii": "", "ad2.AnomalyOperatingIncome": 0, "ad2.IncomeBeforeTaxesGL_i": "", "ad2.IncomeBeforeTaxesGL_ii": "", "ad2.IncomeBeforeTaxesGL_iii": "", "ad2.AnomalyIncomeBeforeTaxes": 0, "ad2.NetIncomeGL_i": "", "ad2.NetIncomeGL_ii": "", "ad2.NetIncomeGL_iii": "", "ad2.AnomalyNetIncome": 0, "ad2.OtherComprehensiveIncome": 340984, "ad2.ComprehensiveIncome": 0, "ad2.OtherComprehensiveIncomeGL_i": "", "ad2.OtherComprehensiveIncomeGL_ii": "", "ad2.OtherComprehensiveIncomeGL_iii": "", "ad2.AnomalyOtherComprehensiveIncome": 0, "ad2.AnomalyComprehensiveIncome": 0, "ad2.ShareholdersEquityBeginning": 0, "ad2.ConvertibleDebt": 0, "ad2.CommonShares": 0, "ad2.PreferredShares": 0, "ad2.RetainedEarnings": 0, "ad2.AccumulatedOtherComprehensiveIncome": 0, "ad2.TreasuryShares": 0, "ad2.EmployeeBenefitTrust": 0, "ad2.NonControllingInterests": 0, "ad2.AnomalyConvertibleDebt": 0, "ad2.AnomalyCommonShares": 35910652, "ad2.AnomalyPreferredShares": 0, "ad2.AnomalyRetainedEarnings": 594431, "ad2.AnomalyAccumulatedOtherComprehensiveIncome": -340984, "ad2.AnomalyTreasuryShares": 0, "ad2.AnomalyEmployeeBenefitTrust": 0, "ad2.AnomalyNonControllingInterests": 0, "ad2.ShareholdersEquityGL_i": "", "ad2.ShareholdersEquityGL_ii": "", "ad2.ShareholdersEquityGL_iii": "", "ad2.OperatingActivities": 0, "ad2.InvestingActivities": 0, "ad2.FinancingActivities": 0, "ad2.IncreaseDecreaseInCash": 0, "ad2.CashFlowCashExplainedDifference": 0, "ad2.OperatingActivitiesGL_i": "", "ad2.OperatingActivitiesGL_ii": "", "ad2.OperatingActivitiesGL_iii": "", "ad2.AnomalyOperatingActivities": 0, "ad2.AnomalyOperatingActivitiesSEC": 0, "ad2.InvestingActivitiesGL_i": "", "ad2.InvestingActivitiesGL_ii": "", "ad2.InvestingActivitiesGL_iii": "", "ad2.AnomalyInvestingActivities": 0, "ad2.AnomalyInvestingActivitiesSEC": 0, "ad2.FinancingActivitiesGL_i": "", "ad2.FinancingActivitiesGL_ii": "", "ad2.FinancingActivitiesGL_iii": "", "ad2.AnomalyFinancingActivities": 45000, "ad2.AnomalyFinancingActivitiesSEC": 0, "ad2.TargetWorkingCapital": 1.2, "ad2.ReinvestmentOfMaintenance": 662295, "ad2.NormalizedDividendPaymentToNonControllingInterests": 0, "ad2.NormalizedDividendPaymentToPreferredShareholders": 0, "ad2.TheoricalInterestRate": 0.035, "ad2.TheoricalTaxRate": 0.32453739810668997, "ad2.CapitalizationRateFloor": 0.021, "ad3.db": 0, "ad3.AccessionNumber": "0001193125-19-057945", "ad3.AmendmentFlag": "", "ad3.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "ad3.Period": "thirdlastyear", "ad3.PeriodEndDate": "2018-11-30", "ad3.TradingSymbol": "CCEL", "ad3.CurrentAssets": 29535210, "ad3.NonCurrentAssets": 12854933, "ad3.Assets": 0, "ad3.CurrentLiabilities": -15429725, "ad3.NonCurrentLiabilities": -37293716, "ad3.Liabilities": 0, "ad3.ShareholdersEquity": 8908298, "ad3.LiabilitiesAndShareholdersEquity": 0, "ad3.CurrentAssetsGL_i": "", "ad3.CurrentAssetsGL_ii": "", "ad3.CurrentAssetsGL_iii": "", "ad3.AnomalyCurrentAssets": 0, "ad3.AnomalyCurrentAssetsSEC": 0, "ad3.NonCurrentAssetsGL_i": "", "ad3.NonCurrentAssetsGL_ii": "", "ad3.NonCurrentAssetsGL_iii": "", "ad3.AnomalyNonCurrentAssets": 0, "ad3.AnomalyNonCurrentAssetsSEC": 0, "ad3.AnomalyAssets": 0, "ad3.CurrentLiabilitiesGL_i": "", "ad3.CurrentLiabilitiesGL_ii": "", "ad3.CurrentLiabilitiesGL_iii": "", "ad3.AnomalyCurrentLiabilities": 0, "ad3.AnomalyCurrentLiabilitiesSEC": 0, "ad3.NonCurrentLiabilitiesGL_i": "", "ad3.NonCurrentLiabilitiesGL_ii": "", "ad3.NonCurrentLiabilitiesGL_iii": "", "ad3.AnomalyNonCurrentLiabilities": -2850000, "ad3.AnomalyNonCurrentLiabilitiesSEC": 0, "ad3.AnomalyLiabilities": 0, "ad3.AnomalyShareholdersEquity": 35515382, "ad3.ShareholdersEquityBalanceGL_i": "", "ad3.ShareholdersEquityBalanceGL_ii": "", "ad3.ShareholdersEquityBalanceGL_iii": "", "ad3.AnomalyShareholdersEquitySEC": 0, "ad3.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad3.Sales": 0, "ad3.CostOfSales": 0, "ad3.GrossMargin": 8435339, "ad3.OperatingExpenses": 0, "ad3.OperatingIncome": -5189303, "ad3.IncomeBeforeTaxes": -3617680, "ad3.NetIncome": 854824, "ad3.NetIncomeAttributableToNonControllingInterest": 0, "ad3.GrossMarginGL_i": "", "ad3.GrossMarginGL_ii": "", "ad3.GrossMarginGL_iii": "", "ad3.AnomalyGrossMargin": 0, "ad3.OperatingExpensesGL_i": "", "ad3.OperatingExpensesGL_ii": "", "ad3.OperatingExpensesGL_iii": "", "ad3.AnomalyOperatingExpenses": 0, "ad3.OperatingIncomeGL_i": "", "ad3.OperatingIncomeGL_ii": "", "ad3.OperatingIncomeGL_iii": "", "ad3.AnomalyOperatingIncome": 0, "ad3.IncomeBeforeTaxesGL_i": "", "ad3.IncomeBeforeTaxesGL_ii": "", "ad3.IncomeBeforeTaxesGL_iii": "", "ad3.AnomalyIncomeBeforeTaxes": 0, "ad3.NetIncomeGL_i": "", "ad3.NetIncomeGL_ii": "", "ad3.NetIncomeGL_iii": "", "ad3.AnomalyNetIncome": 0, "ad3.OtherComprehensiveIncome": -300119, "ad3.ComprehensiveIncome": 0, "ad3.OtherComprehensiveIncomeGL_i": "", "ad3.OtherComprehensiveIncomeGL_ii": "", "ad3.OtherComprehensiveIncomeGL_iii": "", "ad3.AnomalyOtherComprehensiveIncome": 554705, "ad3.AnomalyComprehensiveIncome": 0, "ad3.ShareholdersEquityBeginning": 0, "ad3.ConvertibleDebt": 0, "ad3.CommonShares": 0, "ad3.PreferredShares": 0, "ad3.RetainedEarnings": 0, "ad3.AccumulatedOtherComprehensiveIncome": 0, "ad3.TreasuryShares": 0, "ad3.EmployeeBenefitTrust": 0, "ad3.NonControllingInterests": 0, "ad3.AnomalyConvertibleDebt": 0, "ad3.AnomalyCommonShares": -35733996, "ad3.AnomalyPreferredShares": 0, "ad3.AnomalyRetainedEarnings": 0, "ad3.AnomalyAccumulatedOtherComprehensiveIncome": -554705, "ad3.AnomalyTreasuryShares": 0, "ad3.AnomalyEmployeeBenefitTrust": 0, "ad3.AnomalyNonControllingInterests": 0, "ad3.ShareholdersEquityGL_i": "", "ad3.ShareholdersEquityGL_ii": "", "ad3.ShareholdersEquityGL_iii": "", "ad3.OperatingActivities": 0, "ad3.InvestingActivities": 0, "ad3.FinancingActivities": 0, "ad3.IncreaseDecreaseInCash": 0, "ad3.CashFlowCashExplainedDifference": 0, "ad3.OperatingActivitiesGL_i": "", "ad3.OperatingActivitiesGL_ii": "", "ad3.OperatingActivitiesGL_iii": "", "ad3.AnomalyOperatingActivities": 0, "ad3.AnomalyOperatingActivitiesSEC": 0, "ad3.InvestingActivitiesGL_i": "", "ad3.InvestingActivitiesGL_ii": "", "ad3.InvestingActivitiesGL_iii": "", "ad3.AnomalyInvestingActivities": 0, "ad3.AnomalyInvestingActivitiesSEC": 0, "ad3.FinancingActivitiesGL_i": "", "ad3.FinancingActivitiesGL_ii": "", "ad3.FinancingActivitiesGL_iii": "", "ad3.AnomalyFinancingActivities": 0, "ad3.AnomalyFinancingActivitiesSEC": 0, "ad3.TargetWorkingCapital": 1.2, "ad3.ReinvestmentOfMaintenance": 446163, "ad3.NormalizedDividendPaymentToNonControllingInterests": 0, "ad3.NormalizedDividendPaymentToPreferredShareholders": 0, "ad3.TheoricalInterestRate": 0.035, "ad3.TheoricalTaxRate": 0.35, "ad3.CapitalizationRateFloor": 0.021, "ad4.db": 0, "ad4.AccessionNumber": "0001193125-18-064199", "ad4.AmendmentFlag": "", "ad4.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "ad4.Period": "fourthlastyear", "ad4.PeriodEndDate": "2017-11-30", "ad4.TradingSymbol": "CCEL", "ad4.CurrentAssets": 12736921, "ad4.NonCurrentAssets": 11173076, "ad4.Assets": 0, "ad4.CurrentLiabilities": -13939846, "ad4.NonCurrentLiabilities": -23898047, "ad4.Liabilities": 0, "ad4.ShareholdersEquity": 12502896, "ad4.LiabilitiesAndShareholdersEquity": 0, "ad4.CurrentAssetsGL_i": "", "ad4.CurrentAssetsGL_ii": "", "ad4.CurrentAssetsGL_iii": "", "ad4.AnomalyCurrentAssets": 0, "ad4.AnomalyCurrentAssetsSEC": 0, "ad4.NonCurrentAssetsGL_i": "", "ad4.NonCurrentAssetsGL_ii": "", "ad4.NonCurrentAssetsGL_iii": "", "ad4.AnomalyNonCurrentAssets": 0, "ad4.AnomalyNonCurrentAssetsSEC": 0, "ad4.AnomalyAssets": 0, "ad4.CurrentLiabilitiesGL_i": "", "ad4.CurrentLiabilitiesGL_ii": "", "ad4.CurrentLiabilitiesGL_iii": "", "ad4.AnomalyCurrentLiabilities": 0, "ad4.AnomalyCurrentLiabilitiesSEC": 0, "ad4.NonCurrentLiabilitiesGL_i": "", "ad4.NonCurrentLiabilitiesGL_ii": "", "ad4.NonCurrentLiabilitiesGL_iii": "", "ad4.AnomalyNonCurrentLiabilities": -2850000, "ad4.AnomalyNonCurrentLiabilitiesSEC": 0, "ad4.AnomalyLiabilities": 0, "ad4.AnomalyShareholdersEquity": 0, "ad4.ShareholdersEquityBalanceGL_i": "", "ad4.ShareholdersEquityBalanceGL_ii": "", "ad4.ShareholdersEquityBalanceGL_iii": "", "ad4.AnomalyShareholdersEquitySEC": 0, "ad4.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad4.Sales": 0, "ad4.CostOfSales": 0, "ad4.GrossMargin": -18659888, "ad4.OperatingExpenses": 0, "ad4.OperatingIncome": -5006226, "ad4.IncomeBeforeTaxes": -3623703, "ad4.NetIncome": -2315100, "ad4.NetIncomeAttributableToNonControllingInterest": 0, "ad4.GrossMarginGL_i": "", "ad4.GrossMarginGL_ii": "", "ad4.GrossMarginGL_iii": "", "ad4.AnomalyGrossMargin": 0, "ad4.OperatingExpensesGL_i": "", "ad4.OperatingExpensesGL_ii": "", "ad4.OperatingExpensesGL_iii": "", "ad4.AnomalyOperatingExpenses": 0, "ad4.OperatingIncomeGL_i": "", "ad4.OperatingIncomeGL_ii": "", "ad4.OperatingIncomeGL_iii": "", "ad4.AnomalyOperatingIncome": 0, "ad4.IncomeBeforeTaxesGL_i": "", "ad4.IncomeBeforeTaxesGL_ii": "", "ad4.IncomeBeforeTaxesGL_iii": "", "ad4.AnomalyIncomeBeforeTaxes": 0, "ad4.NetIncomeGL_i": "", "ad4.NetIncomeGL_ii": "", "ad4.NetIncomeGL_iii": "", "ad4.AnomalyNetIncome": 0, "ad4.OtherComprehensiveIncome": -6457, "ad4.ComprehensiveIncome": 0, "ad4.OtherComprehensiveIncomeGL_i": "", "ad4.OtherComprehensiveIncomeGL_ii": "", "ad4.OtherComprehensiveIncomeGL_iii": "", "ad4.AnomalyOtherComprehensiveIncome": 0, "ad4.AnomalyComprehensiveIncome": 0, "ad4.ShareholdersEquityBeginning": 0, "ad4.ConvertibleDebt": 0, "ad4.CommonShares": 0, "ad4.PreferredShares": 0, "ad4.RetainedEarnings": 0, "ad4.AccumulatedOtherComprehensiveIncome": 0, "ad4.TreasuryShares": 0, "ad4.EmployeeBenefitTrust": 0, "ad4.NonControllingInterests": 0, "ad4.AnomalyConvertibleDebt": 0, "ad4.AnomalyCommonShares": 576677, "ad4.AnomalyPreferredShares": 0, "ad4.AnomalyRetainedEarnings": 0, "ad4.AnomalyAccumulatedOtherComprehensiveIncome": 0, "ad4.AnomalyTreasuryShares": 0, "ad4.AnomalyEmployeeBenefitTrust": 0, "ad4.AnomalyNonControllingInterests": 0, "ad4.ShareholdersEquityGL_i": "", "ad4.ShareholdersEquityGL_ii": "", "ad4.ShareholdersEquityGL_iii": "", "ad4.OperatingActivities": 0, "ad4.InvestingActivities": 0, "ad4.FinancingActivities": 0, "ad4.IncreaseDecreaseInCash": 0, "ad4.CashFlowCashExplainedDifference": 0, "ad4.OperatingActivitiesGL_i": "", "ad4.OperatingActivitiesGL_ii": "", "ad4.OperatingActivitiesGL_iii": "", "ad4.AnomalyOperatingActivities": 0, "ad4.AnomalyOperatingActivitiesSEC": 0, "ad4.InvestingActivitiesGL_i": "", "ad4.InvestingActivitiesGL_ii": "", "ad4.InvestingActivitiesGL_iii": "", "ad4.AnomalyInvestingActivities": 0, "ad4.AnomalyInvestingActivitiesSEC": 0, "ad4.FinancingActivitiesGL_i": "", "ad4.FinancingActivitiesGL_ii": "", "ad4.FinancingActivitiesGL_iii": "", "ad4.AnomalyFinancingActivities": 0, "ad4.AnomalyFinancingActivitiesSEC": 0, "ad4.TargetWorkingCapital": 1.2, "ad4.ReinvestmentOfMaintenance": 98333, "ad4.NormalizedDividendPaymentToNonControllingInterests": 0, "ad4.NormalizedDividendPaymentToPreferredShareholders": 0, "ad4.TheoricalInterestRate": 0.035, "ad4.TheoricalTaxRate": 0.35, "ad4.CapitalizationRateFloor": 0.021, "ad5.db": 0, "ad5.AccessionNumber": "0001193125-17-062739", "ad5.AmendmentFlag": "", "ad5.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "ad5.Period": "fifthlastyear", "ad5.PeriodEndDate": "2016-11-30", "ad5.TradingSymbol": "CCEL", "ad5.CurrentAssets": 9011923, "ad5.NonCurrentAssets": 10526545, "ad5.Assets": 0, "ad5.CurrentLiabilities": -13111684, "ad5.NonCurrentLiabilities": -23266042, "ad5.Liabilities": 0, "ad5.ShareholdersEquity": 15414258, "ad5.LiabilitiesAndShareholdersEquity": 0, "ad5.CurrentAssetsGL_i": "", "ad5.CurrentAssetsGL_ii": "", "ad5.CurrentAssetsGL_iii": "", "ad5.AnomalyCurrentAssets": 0, "ad5.AnomalyCurrentAssetsSEC": 0, "ad5.NonCurrentAssetsGL_i": "", "ad5.NonCurrentAssetsGL_ii": "", "ad5.NonCurrentAssetsGL_iii": "", "ad5.AnomalyNonCurrentAssets": 0, "ad5.AnomalyNonCurrentAssetsSEC": 0, "ad5.AnomalyAssets": 0, "ad5.CurrentLiabilitiesGL_i": "", "ad5.CurrentLiabilitiesGL_ii": "", "ad5.CurrentLiabilitiesGL_iii": "", "ad5.AnomalyCurrentLiabilities": 0, "ad5.AnomalyCurrentLiabilitiesSEC": 0, "ad5.NonCurrentLiabilitiesGL_i": "", "ad5.NonCurrentLiabilitiesGL_ii": "", "ad5.NonCurrentLiabilitiesGL_iii": "", "ad5.AnomalyNonCurrentLiabilities": -2850000, "ad5.AnomalyNonCurrentLiabilitiesSEC": 0, "ad5.AnomalyLiabilities": 0, "ad5.AnomalyShareholdersEquity": 0, "ad5.ShareholdersEquityBalanceGL_i": "", "ad5.ShareholdersEquityBalanceGL_ii": "", "ad5.ShareholdersEquityBalanceGL_iii": "", "ad5.AnomalyShareholdersEquitySEC": 0, "ad5.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad5.Sales": 0, "ad5.CostOfSales": 0, "ad5.GrossMargin": -17353247, "ad5.OperatingExpenses": 0, "ad5.OperatingIncome": -433594, "ad5.IncomeBeforeTaxes": 2480212, "ad5.NetIncome": 1320800, "ad5.NetIncomeAttributableToNonControllingInterest": 0, "ad5.GrossMarginGL_i": "", "ad5.GrossMarginGL_ii": "", "ad5.GrossMarginGL_iii": "", "ad5.AnomalyGrossMargin": 0, "ad5.OperatingExpensesGL_i": "", "ad5.OperatingExpensesGL_ii": "", "ad5.OperatingExpensesGL_iii": "", "ad5.AnomalyOperatingExpenses": 0, "ad5.OperatingIncomeGL_i": "", "ad5.OperatingIncomeGL_ii": "", "ad5.OperatingIncomeGL_iii": "", "ad5.AnomalyOperatingIncome": 0, "ad5.IncomeBeforeTaxesGL_i": "", "ad5.IncomeBeforeTaxesGL_ii": "", "ad5.IncomeBeforeTaxesGL_iii": "", "ad5.AnomalyIncomeBeforeTaxes": 0, "ad5.NetIncomeGL_i": "", "ad5.NetIncomeGL_ii": "", "ad5.NetIncomeGL_iii": "", "ad5.AnomalyNetIncome": 0, "ad5.OtherComprehensiveIncome": 135524, "ad5.ComprehensiveIncome": 0, "ad5.OtherComprehensiveIncomeGL_i": "", "ad5.OtherComprehensiveIncomeGL_ii": "", "ad5.OtherComprehensiveIncomeGL_iii": "", "ad5.AnomalyOtherComprehensiveIncome": 1320800, "ad5.AnomalyComprehensiveIncome": 0, "ad5.ShareholdersEquityBeginning": 0, "ad5.ConvertibleDebt": 0, "ad5.CommonShares": 0, "ad5.PreferredShares": 0, "ad5.RetainedEarnings": 0, "ad5.AccumulatedOtherComprehensiveIncome": 0, "ad5.TreasuryShares": 0, "ad5.EmployeeBenefitTrust": 0, "ad5.NonControllingInterests": 0, "ad5.AnomalyConvertibleDebt": 0, "ad5.AnomalyCommonShares": 30181153, "ad5.AnomalyPreferredShares": 0, "ad5.AnomalyRetainedEarnings": 0, "ad5.AnomalyAccumulatedOtherComprehensiveIncome": -1456324, "ad5.AnomalyTreasuryShares": 0, "ad5.AnomalyEmployeeBenefitTrust": 0, "ad5.AnomalyNonControllingInterests": 0, "ad5.ShareholdersEquityGL_i": "", "ad5.ShareholdersEquityGL_ii": "", "ad5.ShareholdersEquityGL_iii": "", "ad5.OperatingActivities": 0, "ad5.InvestingActivities": 0, "ad5.FinancingActivities": 0, "ad5.IncreaseDecreaseInCash": 0, "ad5.CashFlowCashExplainedDifference": 0, "ad5.OperatingActivitiesGL_i": "", "ad5.OperatingActivitiesGL_ii": "", "ad5.OperatingActivitiesGL_iii": "", "ad5.AnomalyOperatingActivities": 0, "ad5.AnomalyOperatingActivitiesSEC": 0, "ad5.InvestingActivitiesGL_i": "", "ad5.InvestingActivitiesGL_ii": "", "ad5.InvestingActivitiesGL_iii": "", "ad5.AnomalyInvestingActivities": 0, "ad5.AnomalyInvestingActivitiesSEC": 0, "ad5.FinancingActivitiesGL_i": "", "ad5.FinancingActivitiesGL_ii": "", "ad5.FinancingActivitiesGL_iii": "", "ad5.AnomalyFinancingActivities": 3400000, "ad5.AnomalyFinancingActivitiesSEC": 0, "ad5.TargetWorkingCapital": 1.2, "ad5.ReinvestmentOfMaintenance": 342982, "ad5.NormalizedDividendPaymentToNonControllingInterests": 0, "ad5.NormalizedDividendPaymentToPreferredShareholders": 0, "ad5.TheoricalInterestRate": 0.035, "ad5.TheoricalTaxRate": 0.35, "ad5.CapitalizationRateFloor": 0.021, "ad6.db": 0, "ad6.AccessionNumber": "0001193125-16-485790", "ad6.AmendmentFlag": "", "ad6.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "ad6.Period": "sixthlastyear", "ad6.PeriodEndDate": "2015-11-30", "ad6.TradingSymbol": "CCEL", "ad6.CurrentAssets": 10353128, "ad6.NonCurrentAssets": 9144818, "ad6.Assets": 0, "ad6.CurrentLiabilities": -10423952, "ad6.NonCurrentLiabilities": -16338165, "ad6.Liabilities": 0, "ad6.ShareholdersEquity": 7264171, "ad6.LiabilitiesAndShareholdersEquity": 0, "ad6.CurrentAssetsGL_i": "", "ad6.CurrentAssetsGL_ii": "", "ad6.CurrentAssetsGL_iii": "", "ad6.AnomalyCurrentAssets": 0, "ad6.AnomalyCurrentAssetsSEC": 0, "ad6.NonCurrentAssetsGL_i": "", "ad6.NonCurrentAssetsGL_ii": "", "ad6.NonCurrentAssetsGL_iii": "", "ad6.AnomalyNonCurrentAssets": 0, "ad6.AnomalyNonCurrentAssetsSEC": 0, "ad6.AnomalyAssets": 0, "ad6.CurrentLiabilitiesGL_i": "", "ad6.CurrentLiabilitiesGL_ii": "", "ad6.CurrentLiabilitiesGL_iii": "", "ad6.AnomalyCurrentLiabilities": 0, "ad6.AnomalyCurrentLiabilitiesSEC": 0, "ad6.NonCurrentLiabilitiesGL_i": "", "ad6.NonCurrentLiabilitiesGL_ii": "", "ad6.NonCurrentLiabilitiesGL_iii": "", "ad6.AnomalyNonCurrentLiabilities": -4600000, "ad6.AnomalyNonCurrentLiabilitiesSEC": 0, "ad6.AnomalyLiabilities": 0, "ad6.AnomalyShareholdersEquity": 18034888, "ad6.ShareholdersEquityBalanceGL_i": "", "ad6.ShareholdersEquityBalanceGL_ii": "", "ad6.ShareholdersEquityBalanceGL_iii": "", "ad6.AnomalyShareholdersEquitySEC": 0, "ad6.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad6.Sales": 0, "ad6.CostOfSales": 0, "ad6.GrossMargin": -15460566, "ad6.OperatingExpenses": 0, "ad6.OperatingIncome": -2933224, "ad6.IncomeBeforeTaxes": -949521, "ad6.NetIncome": -8106343, "ad6.NetIncomeAttributableToNonControllingInterest": 0, "ad6.GrossMarginGL_i": "", "ad6.GrossMarginGL_ii": "", "ad6.GrossMarginGL_iii": "", "ad6.AnomalyGrossMargin": 0, "ad6.OperatingExpensesGL_i": "", "ad6.OperatingExpensesGL_ii": "", "ad6.OperatingExpensesGL_iii": "", "ad6.AnomalyOperatingExpenses": 0, "ad6.OperatingIncomeGL_i": "", "ad6.OperatingIncomeGL_ii": "", "ad6.OperatingIncomeGL_iii": "", "ad6.AnomalyOperatingIncome": 0, "ad6.IncomeBeforeTaxesGL_i": "", "ad6.IncomeBeforeTaxesGL_ii": "", "ad6.IncomeBeforeTaxesGL_iii": "", "ad6.AnomalyIncomeBeforeTaxes": 0, "ad6.NetIncomeGL_i": "", "ad6.NetIncomeGL_ii": "", "ad6.NetIncomeGL_iii": "", "ad6.AnomalyNetIncome": 0, "ad6.OtherComprehensiveIncome": -169932, "ad6.ComprehensiveIncome": 0, "ad6.OtherComprehensiveIncomeGL_i": "", "ad6.OtherComprehensiveIncomeGL_ii": "", "ad6.OtherComprehensiveIncomeGL_iii": "", "ad6.AnomalyOtherComprehensiveIncome": 0, "ad6.AnomalyComprehensiveIncome": 0, "ad6.ShareholdersEquityBeginning": 0, "ad6.ConvertibleDebt": 0, "ad6.CommonShares": 0, "ad6.PreferredShares": 0, "ad6.RetainedEarnings": 0, "ad6.AccumulatedOtherComprehensiveIncome": 0, "ad6.TreasuryShares": 0, "ad6.EmployeeBenefitTrust": 0, "ad6.NonControllingInterests": 0, "ad6.AnomalyConvertibleDebt": 0, "ad6.AnomalyCommonShares": 0, "ad6.AnomalyPreferredShares": 0, "ad6.AnomalyRetainedEarnings": 0, "ad6.AnomalyAccumulatedOtherComprehensiveIncome": 0, "ad6.AnomalyTreasuryShares": 0, "ad6.AnomalyEmployeeBenefitTrust": 0, "ad6.AnomalyNonControllingInterests": 0, "ad6.ShareholdersEquityGL_i": "", "ad6.ShareholdersEquityGL_ii": "", "ad6.ShareholdersEquityGL_iii": "", "ad6.OperatingActivities": 0, "ad6.InvestingActivities": 0, "ad6.FinancingActivities": 0, "ad6.IncreaseDecreaseInCash": 0, "ad6.CashFlowCashExplainedDifference": -204344, "ad6.OperatingActivitiesGL_i": "", "ad6.OperatingActivitiesGL_ii": "", "ad6.OperatingActivitiesGL_iii": "", "ad6.AnomalyOperatingActivities": 0, "ad6.AnomalyOperatingActivitiesSEC": 0, "ad6.InvestingActivitiesGL_i": "", "ad6.InvestingActivitiesGL_ii": "", "ad6.InvestingActivitiesGL_iii": "", "ad6.AnomalyInvestingActivities": 375374, "ad6.AnomalyInvestingActivitiesSEC": 0, "ad6.FinancingActivitiesGL_i": "", "ad6.FinancingActivitiesGL_ii": "", "ad6.FinancingActivitiesGL_iii": "", "ad6.AnomalyFinancingActivities": 0, "ad6.AnomalyFinancingActivitiesSEC": 0, "ad6.TargetWorkingCapital": 1.2, "ad6.ReinvestmentOfMaintenance": 108480, "ad6.NormalizedDividendPaymentToNonControllingInterests": 0, "ad6.NormalizedDividendPaymentToPreferredShareholders": 0, "ad6.TheoricalInterestRate": 0.035, "ad6.TheoricalTaxRate": 0.15, "ad6.CapitalizationRateFloor": 0.021, "cf1.AccessionNumber": "0001564590-21-009945", "cf1.AmendmentFlag": "", "cf1.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "cf1.Period": "lastyear", "cf1.PeriodEndDate": "2020-11-30", "cf1.TradingSymbol": "CCEL", "cf1.CashBeginningBalance": 6541037, "cf1.EffectOfExchangeRateOnCash": 0, "cf1.DepreciationDepletionAndAmortization": 635975, "cf1.GainRelatedToDisposalOrSale": 9162, "cf1.RestructuringAndOtherSpecialCharges": 1284238, "cf1.AccruedEmployeeCompensation": 0, "cf1.ShareBasedCompensation": 0, "cf1.IncreaseDecreaseInIncomeTaxExpenseBenefit": -1283973, "cf1.OtherNonCashIncomeExpense": 85062, "cf1.IncreaseDecreaseInAccountsReceivable": -225629, "cf1.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -178973, "cf1.IncreaseDecreaseInInventories": 454943, "cf1.IncreaseDecreaseInOtherReceivables": 0, "cf1.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 680410, "cf1.IncreaseDecreaseInContractWithCustomerLiability": 3875849, "cf1.IncreaseDecreaseInRetirementBenefits": 0, "cf1.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf1.IncreaseDecreaseOperatingLeaseCurrent": -263573, "cf1.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf1.IncreaseDecreaseInOtherOperatingActivities": -231484, "cf1.PaymentsToAcquireInvestments": 807447, "cf1.ProceedsOfInvestments": 0, "cf1.PaymentsToAcquirePropertyPlantAndEquipment": -99962, "cf1.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf1.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf1.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf1.ProceedsRelatedToInsuranceSettlement": 0, "cf1.ReveiptOfGovernmentGrants": 0, "cf1.PaymentOfLicenseFee": 0, "cf1.InvestingActivitiesInDiscontinuedOperations": 0, "cf1.OtherInvestingActivities": -350000, "cf1.FinanceLeasePrincipalPayments": 0, "cf1.ProceedsFromIssuanceOfCommonShares": 0, "cf1.ProceedsFromSharePurchasePlanAndOptionsExercice": 41000, "cf1.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf1.PaymentsForRepurchaseOfCommonShares": 0, "cf1.PaymentsOfDividends": 0, "cf1.IncreaseDecreaseDeferredContingentConsideration": 0, "cf1.ProceedsFromIssuanceOfLongTermDebt": 0, "cf1.RepaymentsOfLongTermDebt": -3100000, "cf1.FinancingCosts": 0, "cf1.NetChangeInShortTermBorrowings": 0, "cf1.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf1.NetChangeInNonControllingInterests": 0, "cf1.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf1.RepaymentsOfConvertible": 0, "cf1.IssuanceOfConvertible": 0, "cf1.EquityInvesteeAdvancesRepayments": 0, "cf1.OtherFinancingActivities": -1945000, "cf1.CashPaidForTaxes": 0, "cf1.CashPaidForInterest": 0, "cf2.AccessionNumber": "0001193125-20-056695", "cf2.AmendmentFlag": "", "cf2.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "cf2.Period": "secondlastyear", "cf2.PeriodEndDate": "2019-11-30", "cf2.TradingSymbol": "CCEL", "cf2.CashBeginningBalance": 6040033, "cf2.EffectOfExchangeRateOnCash": 0, "cf2.DepreciationDepletionAndAmortization": 401311, "cf2.GainRelatedToDisposalOrSale": 0, "cf2.RestructuringAndOtherSpecialCharges": 2332763, "cf2.AccruedEmployeeCompensation": 0, "cf2.ShareBasedCompensation": 0, "cf2.IncreaseDecreaseInIncomeTaxExpenseBenefit": -1517289, "cf2.OtherNonCashIncomeExpense": 112642, "cf2.IncreaseDecreaseInAccountsReceivable": -229996, "cf2.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -22749, "cf2.IncreaseDecreaseInInventories": -27423, "cf2.IncreaseDecreaseInOtherReceivables": 0, "cf2.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -491742, "cf2.IncreaseDecreaseInContractWithCustomerLiability": 3825996, "cf2.IncreaseDecreaseInRetirementBenefits": 0, "cf2.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf2.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf2.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf2.IncreaseDecreaseInOtherOperatingActivities": -351080, "cf2.PaymentsToAcquireInvestments": -28364, "cf2.ProceedsOfInvestments": 0, "cf2.PaymentsToAcquirePropertyPlantAndEquipment": -662295, "cf2.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf2.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf2.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf2.ProceedsRelatedToInsuranceSettlement": 0, "cf2.ReveiptOfGovernmentGrants": 0, "cf2.PaymentOfLicenseFee": 0, "cf2.InvestingActivitiesInDiscontinuedOperations": 0, "cf2.OtherInvestingActivities": 0, "cf2.FinanceLeasePrincipalPayments": 0, "cf2.ProceedsFromIssuanceOfCommonShares": 0, "cf2.ProceedsFromSharePurchasePlanAndOptionsExercice": 5700, "cf2.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf2.PaymentsForRepurchaseOfCommonShares": -992244, "cf2.PaymentsOfDividends": 0, "cf2.IncreaseDecreaseDeferredContingentConsideration": 0, "cf2.ProceedsFromIssuanceOfLongTermDebt": 0, "cf2.RepaymentsOfLongTermDebt": -4100000, "cf2.FinancingCosts": 0, "cf2.NetChangeInShortTermBorrowings": 0, "cf2.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf2.NetChangeInNonControllingInterests": 0, "cf2.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf2.RepaymentsOfConvertible": 0, "cf2.IssuanceOfConvertible": 0, "cf2.EquityInvesteeAdvancesRepayments": 0, "cf2.OtherFinancingActivities": -45000, "cf2.CashPaidForTaxes": 0, "cf2.CashPaidForInterest": 0, "cf3.AccessionNumber": "0001193125-19-057945", "cf3.AmendmentFlag": "", "cf3.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "cf3.Period": "thirdlastyear", "cf3.PeriodEndDate": "2018-11-30", "cf3.TradingSymbol": "CCEL", "cf3.CashBeginningBalance": 6279154, "cf3.EffectOfExchangeRateOnCash": 0, "cf3.DepreciationDepletionAndAmortization": 317326, "cf3.GainRelatedToDisposalOrSale": 162307, "cf3.RestructuringAndOtherSpecialCharges": 0, "cf3.AccruedEmployeeCompensation": 0, "cf3.ShareBasedCompensation": 0, "cf3.IncreaseDecreaseInIncomeTaxExpenseBenefit": 2378491, "cf3.OtherNonCashIncomeExpense": 109292, "cf3.IncreaseDecreaseInAccountsReceivable": -620290, "cf3.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -105796, "cf3.IncreaseDecreaseInInventories": 316650, "cf3.IncreaseDecreaseInOtherReceivables": 0, "cf3.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -546576, "cf3.IncreaseDecreaseInContractWithCustomerLiability": 4095416, "cf3.IncreaseDecreaseInRetirementBenefits": 0, "cf3.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf3.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf3.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf3.IncreaseDecreaseInOtherOperatingActivities": 81334, "cf3.PaymentsToAcquireInvestments": 0, "cf3.ProceedsOfInvestments": 0, "cf3.PaymentsToAcquirePropertyPlantAndEquipment": -446163, "cf3.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf3.PaymentsToAcquireBusinessesAndIntangibles": -200000, "cf3.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf3.ProceedsRelatedToInsuranceSettlement": 0, "cf3.ReveiptOfGovernmentGrants": 0, "cf3.PaymentOfLicenseFee": 0, "cf3.InvestingActivitiesInDiscontinuedOperations": 0, "cf3.OtherInvestingActivities": -10636248, "cf3.FinanceLeasePrincipalPayments": 0, "cf3.ProceedsFromIssuanceOfCommonShares": 0, "cf3.ProceedsFromSharePurchasePlanAndOptionsExercice": 170925, "cf3.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf3.PaymentsForRepurchaseOfCommonShares": 0, "cf3.PaymentsOfDividends": 0, "cf3.IncreaseDecreaseDeferredContingentConsideration": 0, "cf3.ProceedsFromIssuanceOfLongTermDebt": 8830700, "cf3.RepaymentsOfLongTermDebt": -3291665, "cf3.FinancingCosts": 0, "cf3.NetChangeInShortTermBorrowings": 0, "cf3.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf3.NetChangeInNonControllingInterests": 0, "cf3.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf3.RepaymentsOfConvertible": 0, "cf3.IssuanceOfConvertible": 0, "cf3.EquityInvesteeAdvancesRepayments": 0, "cf3.OtherFinancingActivities": 0, "cf3.CashPaidForTaxes": 0, "cf3.CashPaidForInterest": 0, "cf4.AccessionNumber": "0001193125-18-064199", "cf4.AmendmentFlag": "", "cf4.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "cf4.Period": "fourthlastyear", "cf4.PeriodEndDate": "2017-11-30", "cf4.TradingSymbol": "CCEL", "cf4.CashBeginningBalance": 3499881, "cf4.EffectOfExchangeRateOnCash": 0, "cf4.DepreciationDepletionAndAmortization": 229995, "cf4.GainRelatedToDisposalOrSale": 0, "cf4.RestructuringAndOtherSpecialCharges": 0, "cf4.AccruedEmployeeCompensation": 0, "cf4.ShareBasedCompensation": 0, "cf4.IncreaseDecreaseInIncomeTaxExpenseBenefit": -774806, "cf4.OtherNonCashIncomeExpense": 125434, "cf4.IncreaseDecreaseInAccountsReceivable": -1072863, "cf4.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 19961, "cf4.IncreaseDecreaseInInventories": 46576, "cf4.IncreaseDecreaseInOtherReceivables": 0, "cf4.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 414967, "cf4.IncreaseDecreaseInContractWithCustomerLiability": 3513477, "cf4.IncreaseDecreaseInRetirementBenefits": 0, "cf4.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf4.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf4.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf4.IncreaseDecreaseInOtherOperatingActivities": 900332, "cf4.PaymentsToAcquireInvestments": 191358, "cf4.ProceedsOfInvestments": 0, "cf4.PaymentsToAcquirePropertyPlantAndEquipment": -98333, "cf4.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf4.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf4.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf4.ProceedsRelatedToInsuranceSettlement": 0, "cf4.ReveiptOfGovernmentGrants": 0, "cf4.PaymentOfLicenseFee": 0, "cf4.InvestingActivitiesInDiscontinuedOperations": 0, "cf4.OtherInvestingActivities": 0, "cf4.FinanceLeasePrincipalPayments": 0, "cf4.ProceedsFromIssuanceOfCommonShares": 0, "cf4.ProceedsFromSharePurchasePlanAndOptionsExercice": 64696, "cf4.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf4.PaymentsForRepurchaseOfCommonShares": -446621, "cf4.PaymentsOfDividends": 0, "cf4.IncreaseDecreaseDeferredContingentConsideration": 0, "cf4.ProceedsFromIssuanceOfLongTermDebt": 0, "cf4.RepaymentsOfLongTermDebt": -2650000, "cf4.FinancingCosts": 0, "cf4.NetChangeInShortTermBorrowings": 0, "cf4.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf4.NetChangeInNonControllingInterests": 0, "cf4.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf4.RepaymentsOfConvertible": 0, "cf4.IssuanceOfConvertible": 0, "cf4.EquityInvesteeAdvancesRepayments": 0, "cf4.OtherFinancingActivities": 0, "cf4.CashPaidForTaxes": 0, "cf4.CashPaidForInterest": 0, "cf5.AccessionNumber": "0001193125-17-062739", "cf5.AmendmentFlag": "", "cf5.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "cf5.Period": "fifthlastyear", "cf5.PeriodEndDate": "2016-11-30", "cf5.TradingSymbol": "CCEL", "cf5.CashBeginningBalance": 4152162, "cf5.EffectOfExchangeRateOnCash": 0, "cf5.DepreciationDepletionAndAmortization": 286650, "cf5.GainRelatedToDisposalOrSale": 0, "cf5.RestructuringAndOtherSpecialCharges": 1688496, "cf5.AccruedEmployeeCompensation": 0, "cf5.ShareBasedCompensation": 0, "cf5.IncreaseDecreaseInIncomeTaxExpenseBenefit": -1911828, "cf5.OtherNonCashIncomeExpense": 48435, "cf5.IncreaseDecreaseInAccountsReceivable": -994349, "cf5.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 47429, "cf5.IncreaseDecreaseInInventories": 114466, "cf5.IncreaseDecreaseInOtherReceivables": 0, "cf5.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 978402, "cf5.IncreaseDecreaseInContractWithCustomerLiability": 2016436, "cf5.IncreaseDecreaseInRetirementBenefits": 0, "cf5.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf5.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf5.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf5.IncreaseDecreaseInOtherOperatingActivities": 4034638, "cf5.PaymentsToAcquireInvestments": -231090, "cf5.ProceedsOfInvestments": 0, "cf5.PaymentsToAcquirePropertyPlantAndEquipment": -342982, "cf5.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf5.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf5.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf5.ProceedsRelatedToInsuranceSettlement": 0, "cf5.ReveiptOfGovernmentGrants": 0, "cf5.PaymentOfLicenseFee": 0, "cf5.InvestingActivitiesInDiscontinuedOperations": 0, "cf5.OtherInvestingActivities": 204344, "cf5.FinanceLeasePrincipalPayments": 0, "cf5.ProceedsFromIssuanceOfCommonShares": 0, "cf5.ProceedsFromSharePurchasePlanAndOptionsExercice": 40340, "cf5.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf5.PaymentsForRepurchaseOfCommonShares": -10806409, "cf5.PaymentsOfDividends": 0, "cf5.IncreaseDecreaseDeferredContingentConsideration": 0, "cf5.ProceedsFromIssuanceOfLongTermDebt": 10404648, "cf5.RepaymentsOfLongTermDebt": -1509107, "cf5.FinancingCosts": 0, "cf5.NetChangeInShortTermBorrowings": 0, "cf5.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf5.NetChangeInNonControllingInterests": 0, "cf5.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf5.RepaymentsOfConvertible": 0, "cf5.IssuanceOfConvertible": 0, "cf5.EquityInvesteeAdvancesRepayments": 0, "cf5.OtherFinancingActivities": -3400000, "cf5.CashPaidForTaxes": 0, "cf5.CashPaidForInterest": 0, "cf6.AccessionNumber": "0001193125-16-485790", "cf6.AmendmentFlag": "", "cf6.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "cf6.Period": "sixthlastyear", "cf6.PeriodEndDate": "2015-11-30", "cf6.TradingSymbol": "CCEL", "cf6.CashBeginningBalance": 3279267, "cf6.EffectOfExchangeRateOnCash": 0, "cf6.DepreciationDepletionAndAmortization": 241208, "cf6.GainRelatedToDisposalOrSale": 0, "cf6.RestructuringAndOtherSpecialCharges": 684000, "cf6.AccruedEmployeeCompensation": 0, "cf6.ShareBasedCompensation": 0, "cf6.IncreaseDecreaseInIncomeTaxExpenseBenefit": -7369513, "cf6.OtherNonCashIncomeExpense": 0, "cf6.IncreaseDecreaseInAccountsReceivable": 1013618, "cf6.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 190178, "cf6.IncreaseDecreaseInInventories": 117231, "cf6.IncreaseDecreaseInOtherReceivables": 0, "cf6.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": -204537, "cf6.IncreaseDecreaseInContractWithCustomerLiability": 1480140, "cf6.IncreaseDecreaseInRetirementBenefits": 0, "cf6.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf6.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf6.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf6.IncreaseDecreaseInOtherOperatingActivities": 592794, "cf6.PaymentsToAcquireInvestments": -235292, "cf6.ProceedsOfInvestments": 0, "cf6.PaymentsToAcquirePropertyPlantAndEquipment": -108480, "cf6.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf6.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf6.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf6.ProceedsRelatedToInsuranceSettlement": 0, "cf6.ReveiptOfGovernmentGrants": 0, "cf6.PaymentOfLicenseFee": 0, "cf6.InvestingActivitiesInDiscontinuedOperations": 0, "cf6.OtherInvestingActivities": -375577, "cf6.FinanceLeasePrincipalPayments": 0, "cf6.ProceedsFromIssuanceOfCommonShares": 0, "cf6.ProceedsFromSharePurchasePlanAndOptionsExercice": 69850, "cf6.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf6.PaymentsForRepurchaseOfCommonShares": -3205435, "cf6.PaymentsOfDividends": 0, "cf6.IncreaseDecreaseDeferredContingentConsideration": 0, "cf6.ProceedsFromIssuanceOfLongTermDebt": 0, "cf6.RepaymentsOfLongTermDebt": -123633, "cf6.FinancingCosts": 0, "cf6.NetChangeInShortTermBorrowings": 0, "cf6.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf6.NetChangeInNonControllingInterests": 0, "cf6.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf6.RepaymentsOfConvertible": 0, "cf6.IssuanceOfConvertible": 0, "cf6.EquityInvesteeAdvancesRepayments": 0, "cf6.OtherFinancingActivities": 0, "cf6.CashPaidForTaxes": 0, "cf6.CashPaidForInterest": 0, "tb1.AccessionNumber": "0001564590-21-009945", "tb1.AmendmentFlag": "", "tb1.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "tb1.Link": "0", "tb1.Period": "lastyear", "tb1.PeriodEndDate": "2020-11-30", "tb1.PeriodOfReport": "0", "tb1.TradingSymbol": "CCEL", "tb1.Cash": 10361125, "tb1.ShortTermInvestments": 88476, "tb1.AccountsReceivable": 6322960, "tb1.WorkInProgress": 0, "tb1.Inventories": 927318, "tb1.PrepaidExpenses": 611627, "tb1.NonTradeReceivables": 0, "tb1.PrepaidTaxAssetsCurrent": 0, "tb1.DeferredTaxAssetsCurrent": 0, "tb1.RightOfUseAssetsCurrent": 0, "tb1.OtherCurrentAssets": 244696, "tb1.DiscontinuedOperationsCurrent": 0, "tb1.LongTermReceivables": 0, "tb1.DeferredCharges": 0, "tb1.Investments": 0, "tb1.PropertyPlantAndEquipment": 1640774, "tb1.OperatingLeaseRightOfUseAssets": 299089, "tb1.FinanceLeaseRightOfUseAssets": 0, "tb1.IntangibleAssets": 1181588, "tb1.Goodwill": 1941411, "tb1.RefundableTaxAssetsNonCurrent": 0, "tb1.DeferredTaxAssetsNonCurrent": 10363967, "tb1.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.OtherNonCurrentAssets": 12217063, "tb1.DiscontinuedOperations": 0, "tb1.AccountsPayableAndAccruedLiabilities": -6955601, "tb1.EmployeeCompensationCurrent": 0, "tb1.OperatingLeasesCurrent": -275570, "tb1.FinanceLeasesCurrent": 0, "tb1.DeferredRevenueAndDepositsCurrent": -9183450, "tb1.AccruedTaxLiabilities": 0, "tb1.DeferredTaxLiabilitiesCurrent": 0, "tb1.CommercialPapers": 0, "tb1.ShortTermBorrowings": 0, "tb1.OtherCurrentLiabilities": 0, "tb1.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb1.DividendsPayable": 0, "tb1.ShortTermPortionOfLongTermDebt": 0, "tb1.LongTermDebt": -2841214, "tb1.PreferredSharesLiability": 0, "tb1.RetirementBenefits": 0, "tb1.OperatingLeasesNonCurrent": 0, "tb1.FinanceLeasesNonCurrent": 0, "tb1.LeaseIncentiveObligation": 0, "tb1.DeferredRevenueAndDepositsNonCurrent": -27200910, "tb1.ContingentConsideration": -1509852, "tb1.AccruedTaxLiabilitiesNonCurrent": 0, "tb1.DeferredTaxLiabilitiesNonCurrent": 0, "tb1.OtherNonCurrentLiabilities": -1797264, "tb1.RedeemableNonControllingInterests": 0, "tb1.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb1.ConvertibleDebtBeginning": 0, "tb1.CommonSharesBeginning": -36054816, "tb1.CommonSharesIssued": -75729, "tb1.ShareBasedCompensation": -587391, "tb1.PreferredSharesBeginning": 0, "tb1.RetainedEarningsBeginning": 22444310, "tb1.DividendsAndDividendEquivalentsDeclared": 0, "tb1.CommonSharesRepurchasedAndRetired": 0, "tb1.ShareBasedCompensationRetainedEarnings": 0, "tb1.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb1.RetainedEarningsOthers": 0, "tb1.AccumulatedOtherComprehensiveIncomeBeginning": 0, "tb1.TreasurySharesBeginning": 20563357, "tb1.PurchaseAndSellOfTreasuryShares": 0, "tb1.EmployeeBenefitTrustBeginning": 0, "tb1.NonControllingInterestsBeginning": 0, "tb1.DividendsDeclaredToNonControllingInterests": 0, "tb1.AcquisitionOfNonControllingInterests": 0, "tb1.NonControllingInterestsOthers": 0, "tb1.Sales": -244187, "tb1.CostOfSales": 9657442, "tb1.ResearchAndDevelopment": 23851, "tb1.SellingGeneralAdministrativeAndMarketing": -17098703, "tb1.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb1.NonOperatingIncome": 2622274, "tb1.IncomeTaxExpenseBenefit": 1414727, "tb1.EquityMethodInvesteesIncome": 0, "tb1.NetIncomeFromDiscontinuedOperations": 0, "tb1.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb1.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb1.ChangeInUnrealizedGainsLossesOnInvestments": 0, "tb1.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.IncomeTaxOnOtherComprehensiveIncome": 0, "tb2.AccessionNumber": "0001193125-20-056695", "tb2.AmendmentFlag": "", "tb2.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "tb2.Link": "0", "tb2.Period": "secondlastyear", "tb2.PeriodEndDate": "2019-11-30", "tb2.PeriodOfReport": "0", "tb2.TradingSymbol": "CCEL", "tb2.Cash": 6541037, "tb2.ShortTermInvestments": 904053, "tb2.AccountsReceivable": 6097331, "tb2.WorkInProgress": 0, "tb2.Inventories": 1084533, "tb2.PrepaidExpenses": 500260, "tb2.NonTradeReceivables": 0, "tb2.PrepaidTaxAssetsCurrent": 0, "tb2.DeferredTaxAssetsCurrent": 0, "tb2.RightOfUseAssetsCurrent": 0, "tb2.OtherCurrentAssets": 260397, "tb2.DiscontinuedOperationsCurrent": 0, "tb2.LongTermReceivables": 0, "tb2.DeferredCharges": 0, "tb2.Investments": 0, "tb2.PropertyPlantAndEquipment": 1846467, "tb2.OperatingLeaseRightOfUseAssets": 0, "tb2.FinanceLeaseRightOfUseAssets": 0, "tb2.IntangibleAssets": 1249254, "tb2.Goodwill": 1941411, "tb2.RefundableTaxAssetsNonCurrent": 0, "tb2.DeferredTaxAssetsNonCurrent": 9079994, "tb2.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.OtherNonCurrentAssets": 13381423, "tb2.DiscontinuedOperations": 0, "tb2.AccountsPayableAndAccruedLiabilities": -6554291, "tb2.EmployeeCompensationCurrent": 0, "tb2.OperatingLeasesCurrent": 0, "tb2.FinanceLeasesCurrent": 0, "tb2.DeferredRevenueAndDepositsCurrent": -8875138, "tb2.AccruedTaxLiabilities": 0, "tb2.DeferredTaxLiabilitiesCurrent": 0, "tb2.CommercialPapers": 0, "tb2.ShortTermBorrowings": 0, "tb2.OtherCurrentLiabilities": 0, "tb2.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb2.DividendsPayable": 0, "tb2.ShortTermPortionOfLongTermDebt": 0, "tb2.LongTermDebt": -5856152, "tb2.PreferredSharesLiability": 0, "tb2.RetirementBenefits": 0, "tb2.OperatingLeasesNonCurrent": 0, "tb2.FinanceLeasesNonCurrent": 0, "tb2.LeaseIncentiveObligation": 0, "tb2.DeferredRevenueAndDepositsNonCurrent": -23633373, "tb2.ContingentConsideration": -3495057, "tb2.AccruedTaxLiabilitiesNonCurrent": 0, "tb2.DeferredTaxLiabilitiesNonCurrent": 0, "tb2.OtherNonCurrentLiabilities": -2850000, "tb2.RedeemableNonControllingInterests": 0, "tb2.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb2.ConvertibleDebtBeginning": 0, "tb2.CommonSharesBeginning": -135964, "tb2.CommonSharesIssued": -8200, "tb2.ShareBasedCompensation": -35910652, "tb2.PreferredSharesBeginning": 0, "tb2.RetainedEarningsBeginning": 25329515, "tb2.DividendsAndDividendEquivalentsDeclared": 0, "tb2.CommonSharesRepurchasedAndRetired": 0, "tb2.ShareBasedCompensationRetainedEarnings": 0, "tb2.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb2.RetainedEarningsOthers": -594431, "tb2.AccumulatedOtherComprehensiveIncomeBeginning": -340984, "tb2.TreasurySharesBeginning": 19571113, "tb2.PurchaseAndSellOfTreasuryShares": 992244, "tb2.EmployeeBenefitTrustBeginning": 0, "tb2.NonControllingInterestsBeginning": 0, "tb2.DividendsDeclaredToNonControllingInterests": 0, "tb2.AcquisitionOfNonControllingInterests": 0, "tb2.NonControllingInterestsOthers": 0, "tb2.Sales": -172395, "tb2.CostOfSales": 10036175, "tb2.ResearchAndDevelopment": 30145, "tb2.SellingGeneralAdministrativeAndMarketing": -14956631, "tb2.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb2.NonOperatingIncome": 1671291, "tb2.IncomeTaxExpenseBenefit": 1100641, "tb2.EquityMethodInvesteesIncome": 0, "tb2.NetIncomeFromDiscontinuedOperations": 0, "tb2.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb2.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb2.ChangeInUnrealizedGainsLossesOnInvestments": 340984, "tb2.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.IncomeTaxOnOtherComprehensiveIncome": 0, "tb3.AccessionNumber": "0001193125-19-057945", "tb3.AmendmentFlag": "", "tb3.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "tb3.Link": "0", "tb3.Period": "thirdlastyear", "tb3.PeriodEndDate": "2018-11-30", "tb3.PeriodOfReport": "0", "tb3.TradingSymbol": "CCEL", "tb3.Cash": 6040033, "tb3.ShortTermInvestments": 875689, "tb3.AccountsReceivable": 5867335, "tb3.WorkInProgress": 0, "tb3.Inventories": 16035873, "tb3.PrepaidExpenses": 461815, "tb3.NonTradeReceivables": 0, "tb3.PrepaidTaxAssetsCurrent": 0, "tb3.DeferredTaxAssetsCurrent": 0, "tb3.RightOfUseAssetsCurrent": 0, "tb3.OtherCurrentAssets": 254465, "tb3.DiscontinuedOperationsCurrent": 0, "tb3.LongTermReceivables": 0, "tb3.DeferredCharges": 0, "tb3.Investments": 0, "tb3.PropertyPlantAndEquipment": 1493401, "tb3.OperatingLeaseRightOfUseAssets": 0, "tb3.FinanceLeaseRightOfUseAssets": 0, "tb3.IntangibleAssets": 1341336, "tb3.Goodwill": 1941411, "tb3.RefundableTaxAssetsNonCurrent": 0, "tb3.DeferredTaxAssetsNonCurrent": 7656897, "tb3.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.OtherNonCurrentAssets": 421888, "tb3.DiscontinuedOperations": 0, "tb3.AccountsPayableAndAccruedLiabilities": -7064441, "tb3.EmployeeCompensationCurrent": 0, "tb3.OperatingLeasesCurrent": 0, "tb3.FinanceLeasesCurrent": 0, "tb3.DeferredRevenueAndDepositsCurrent": -8365284, "tb3.AccruedTaxLiabilities": 0, "tb3.DeferredTaxLiabilitiesCurrent": 0, "tb3.CommercialPapers": 0, "tb3.ShortTermBorrowings": 0, "tb3.OtherCurrentLiabilities": 0, "tb3.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb3.DividendsPayable": 0, "tb3.ShortTermPortionOfLongTermDebt": 0, "tb3.LongTermDebt": -9843510, "tb3.PreferredSharesLiability": 0, "tb3.RetirementBenefits": 0, "tb3.OperatingLeasesNonCurrent": 0, "tb3.FinanceLeasesNonCurrent": 0, "tb3.LeaseIncentiveObligation": 0, "tb3.DeferredRevenueAndDepositsNonCurrent": -20317231, "tb3.ContingentConsideration": -4282975, "tb3.AccruedTaxLiabilitiesNonCurrent": 0, "tb3.DeferredTaxLiabilitiesNonCurrent": 0, "tb3.OtherNonCurrentLiabilities": -2850000, "tb3.RedeemableNonControllingInterests": 0, "tb3.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb3.ConvertibleDebtBeginning": 0, "tb3.CommonSharesBeginning": -31502043, "tb3.CommonSharesIssued": -4367917, "tb3.ShareBasedCompensation": 35733996, "tb3.PreferredSharesBeginning": 0, "tb3.RetainedEarningsBeginning": 24474691, "tb3.DividendsAndDividendEquivalentsDeclared": 0, "tb3.CommonSharesRepurchasedAndRetired": 0, "tb3.ShareBasedCompensationRetainedEarnings": 0, "tb3.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb3.RetainedEarningsOthers": 0, "tb3.AccumulatedOtherComprehensiveIncomeBeginning": -40865, "tb3.TreasurySharesBeginning": 19571113, "tb3.PurchaseAndSellOfTreasuryShares": 0, "tb3.EmployeeBenefitTrustBeginning": 0, "tb3.NonControllingInterestsBeginning": 0, "tb3.DividendsDeclaredToNonControllingInterests": 0, "tb3.AcquisitionOfNonControllingInterests": 0, "tb3.NonControllingInterestsOthers": 0, "tb3.Sales": -104323, "tb3.CostOfSales": 8539662, "tb3.ResearchAndDevelopment": 91845, "tb3.SellingGeneralAdministrativeAndMarketing": -13716487, "tb3.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb3.NonOperatingIncome": 1571623, "tb3.IncomeTaxExpenseBenefit": 4472504, "tb3.EquityMethodInvesteesIncome": 0, "tb3.NetIncomeFromDiscontinuedOperations": 0, "tb3.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb3.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb3.ChangeInUnrealizedGainsLossesOnInvestments": -300119, "tb3.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.IncomeTaxOnOtherComprehensiveIncome": 0, "tb4.AccessionNumber": "0001193125-18-064199", "tb4.AmendmentFlag": "", "tb4.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "tb4.Link": "0", "tb4.Period": "fourthlastyear", "tb4.PeriodEndDate": "2017-11-30", "tb4.PeriodOfReport": "0", "tb4.TradingSymbol": "CCEL", "tb4.Cash": 6279154, "tb4.ShortTermInvestments": 439322, "tb4.AccountsReceivable": 5125591, "tb4.WorkInProgress": 0, "tb4.Inventories": 314566, "tb4.PrepaidExpenses": 372152, "tb4.NonTradeReceivables": 0, "tb4.PrepaidTaxAssetsCurrent": 0, "tb4.DeferredTaxAssetsCurrent": 0, "tb4.RightOfUseAssetsCurrent": 0, "tb4.OtherCurrentAssets": 206136, "tb4.DiscontinuedOperationsCurrent": 0, "tb4.LongTermReceivables": 0, "tb4.DeferredCharges": 0, "tb4.Investments": 0, "tb4.PropertyPlantAndEquipment": 882382, "tb4.OperatingLeaseRightOfUseAssets": 0, "tb4.FinanceLeaseRightOfUseAssets": 0, "tb4.IntangibleAssets": 226418, "tb4.Goodwill": 0, "tb4.RefundableTaxAssetsNonCurrent": 0, "tb4.DeferredTaxAssetsNonCurrent": 10035388, "tb4.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.OtherNonCurrentAssets": 28888, "tb4.DiscontinuedOperations": 0, "tb4.AccountsPayableAndAccruedLiabilities": -6511017, "tb4.EmployeeCompensationCurrent": 0, "tb4.OperatingLeasesCurrent": 0, "tb4.FinanceLeasesCurrent": 0, "tb4.DeferredRevenueAndDepositsCurrent": -7428829, "tb4.AccruedTaxLiabilities": 0, "tb4.DeferredTaxLiabilitiesCurrent": 0, "tb4.CommercialPapers": 0, "tb4.ShortTermBorrowings": 0, "tb4.OtherCurrentLiabilities": 0, "tb4.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb4.DividendsPayable": 0, "tb4.ShortTermPortionOfLongTermDebt": 0, "tb4.LongTermDebt": -5295183, "tb4.PreferredSharesLiability": 0, "tb4.RetirementBenefits": 0, "tb4.OperatingLeasesNonCurrent": 0, "tb4.FinanceLeasesNonCurrent": 0, "tb4.LeaseIncentiveObligation": 0, "tb4.DeferredRevenueAndDepositsNonCurrent": -15752864, "tb4.ContingentConsideration": 0, "tb4.AccruedTaxLiabilitiesNonCurrent": 0, "tb4.DeferredTaxLiabilitiesNonCurrent": 0, "tb4.OtherNonCurrentLiabilities": -2850000, "tb4.RedeemableNonControllingInterests": 0, "tb4.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb4.ConvertibleDebtBeginning": 0, "tb4.CommonSharesBeginning": -30465617, "tb4.CommonSharesIssued": -459749, "tb4.ShareBasedCompensation": -576677, "tb4.PreferredSharesBeginning": 0, "tb4.RetainedEarningsBeginning": 26789791, "tb4.DividendsAndDividendEquivalentsDeclared": 0, "tb4.CommonSharesRepurchasedAndRetired": 0, "tb4.ShareBasedCompensationRetainedEarnings": 0, "tb4.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb4.RetainedEarningsOthers": 0, "tb4.AccumulatedOtherComprehensiveIncomeBeginning": -34408, "tb4.TreasurySharesBeginning": 19124492, "tb4.PurchaseAndSellOfTreasuryShares": 446621, "tb4.EmployeeBenefitTrustBeginning": 0, "tb4.NonControllingInterestsBeginning": 0, "tb4.DividendsDeclaredToNonControllingInterests": 0, "tb4.AcquisitionOfNonControllingInterests": 0, "tb4.NonControllingInterestsOthers": 0, "tb4.Sales": -25384279, "tb4.CostOfSales": 6724391, "tb4.ResearchAndDevelopment": 41165, "tb4.SellingGeneralAdministrativeAndMarketing": 13612497, "tb4.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb4.NonOperatingIncome": 1382523, "tb4.IncomeTaxExpenseBenefit": 1308603, "tb4.EquityMethodInvesteesIncome": 0, "tb4.NetIncomeFromDiscontinuedOperations": 0, "tb4.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb4.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb4.ChangeInUnrealizedGainsLossesOnInvestments": -6457, "tb4.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.IncomeTaxOnOtherComprehensiveIncome": 0, "tb5.AccessionNumber": "0001193125-17-062739", "tb5.AmendmentFlag": "", "tb5.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "tb5.Link": "0", "tb5.Period": "fifthlastyear", "tb5.PeriodEndDate": "2016-11-30", "tb5.PeriodOfReport": "0", "tb5.TradingSymbol": "CCEL", "tb5.Cash": 3499881, "tb5.ShortTermInvestments": 624223, "tb5.AccountsReceivable": 4052728, "tb5.WorkInProgress": 0, "tb5.Inventories": 361142, "tb5.PrepaidExpenses": 395501, "tb5.NonTradeReceivables": 0, "tb5.PrepaidTaxAssetsCurrent": 0, "tb5.DeferredTaxAssetsCurrent": 0, "tb5.RightOfUseAssetsCurrent": 0, "tb5.OtherCurrentAssets": 78448, "tb5.DiscontinuedOperationsCurrent": 0, "tb5.LongTermReceivables": 0, "tb5.DeferredCharges": 0, "tb5.Investments": 0, "tb5.PropertyPlantAndEquipment": 979463, "tb5.OperatingLeaseRightOfUseAssets": 0, "tb5.FinanceLeaseRightOfUseAssets": 0, "tb5.IntangibleAssets": 261000, "tb5.Goodwill": 0, "tb5.RefundableTaxAssetsNonCurrent": 0, "tb5.DeferredTaxAssetsNonCurrent": 9260582, "tb5.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.OtherNonCurrentAssets": 25500, "tb5.DiscontinuedOperations": 0, "tb5.AccountsPayableAndAccruedLiabilities": -6039760, "tb5.EmployeeCompensationCurrent": 0, "tb5.OperatingLeasesCurrent": 0, "tb5.FinanceLeasesCurrent": 0, "tb5.DeferredRevenueAndDepositsCurrent": -7071924, "tb5.AccruedTaxLiabilities": 0, "tb5.DeferredTaxLiabilitiesCurrent": 0, "tb5.CommercialPapers": 0, "tb5.ShortTermBorrowings": 0, "tb5.OtherCurrentLiabilities": 0, "tb5.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb5.DividendsPayable": 0, "tb5.ShortTermPortionOfLongTermDebt": 0, "tb5.LongTermDebt": -7819750, "tb5.PreferredSharesLiability": 0, "tb5.RetirementBenefits": 0, "tb5.OperatingLeasesNonCurrent": 0, "tb5.FinanceLeasesNonCurrent": 0, "tb5.LeaseIncentiveObligation": 0, "tb5.DeferredRevenueAndDepositsNonCurrent": -12596292, "tb5.ContingentConsideration": 0, "tb5.AccruedTaxLiabilitiesNonCurrent": 0, "tb5.DeferredTaxLiabilitiesNonCurrent": 0, "tb5.OtherNonCurrentLiabilities": -2850000, "tb5.RedeemableNonControllingInterests": 0, "tb5.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb5.ConvertibleDebtBeginning": 0, "tb5.CommonSharesBeginning": 0, "tb5.CommonSharesIssued": -284464, "tb5.ShareBasedCompensation": -30181153, "tb5.PreferredSharesBeginning": 0, "tb5.RetainedEarningsBeginning": 25468991, "tb5.DividendsAndDividendEquivalentsDeclared": 0, "tb5.CommonSharesRepurchasedAndRetired": 0, "tb5.ShareBasedCompensationRetainedEarnings": 0, "tb5.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb5.RetainedEarningsOthers": 0, "tb5.AccumulatedOtherComprehensiveIncomeBeginning": -169932, "tb5.TreasurySharesBeginning": 0, "tb5.PurchaseAndSellOfTreasuryShares": 19124492, "tb5.EmployeeBenefitTrustBeginning": 0, "tb5.NonControllingInterestsBeginning": 0, "tb5.DividendsDeclaredToNonControllingInterests": 0, "tb5.AcquisitionOfNonControllingInterests": 0, "tb5.NonControllingInterestsOthers": 0, "tb5.Sales": -23128047, "tb5.CostOfSales": 5774800, "tb5.ResearchAndDevelopment": 53097, "tb5.SellingGeneralAdministrativeAndMarketing": 16866556, "tb5.ImpairmentRestructuringAndOtherSpecialCharges": 300593, "tb5.NonOperatingIncome": 2613213, "tb5.IncomeTaxExpenseBenefit": -1159412, "tb5.EquityMethodInvesteesIncome": 0, "tb5.NetIncomeFromDiscontinuedOperations": 0, "tb5.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb5.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb5.ChangeInUnrealizedGainsLossesOnInvestments": 135524, "tb5.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.IncomeTaxOnOtherComprehensiveIncome": 0, "tb6.AccessionNumber": "0001193125-16-485790", "tb6.AmendmentFlag": "", "tb6.EntityRegistrantName": "CRYO CELL INTERNATIONAL INC", "tb6.Link": "0", "tb6.Period": "sixthlastyear", "tb6.PeriodEndDate": "2015-11-30", "tb6.PeriodOfReport": "0", "tb6.TradingSymbol": "CCEL", "tb6.Cash": 4356506, "tb6.ShortTermInvestments": 610424, "tb6.AccountsReceivable": 3058379, "tb6.WorkInProgress": 0, "tb6.Inventories": 475608, "tb6.PrepaidExpenses": 427819, "tb6.NonTradeReceivables": 0, "tb6.PrepaidTaxAssetsCurrent": 0, "tb6.DeferredTaxAssetsCurrent": 1336000, "tb6.RightOfUseAssetsCurrent": 0, "tb6.OtherCurrentAssets": 88392, "tb6.DiscontinuedOperationsCurrent": 0, "tb6.LongTermReceivables": 0, "tb6.DeferredCharges": 0, "tb6.Investments": 0, "tb6.PropertyPlantAndEquipment": 879070, "tb6.OperatingLeaseRightOfUseAssets": 0, "tb6.FinanceLeaseRightOfUseAssets": 0, "tb6.IntangibleAssets": 516328, "tb6.Goodwill": 1777822, "tb6.RefundableTaxAssetsNonCurrent": 0, "tb6.DeferredTaxAssetsNonCurrent": 5930987, "tb6.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.OtherNonCurrentAssets": 40611, "tb6.DiscontinuedOperations": 0, "tb6.AccountsPayableAndAccruedLiabilities": -3641390, "tb6.EmployeeCompensationCurrent": 0, "tb6.OperatingLeasesCurrent": 0, "tb6.FinanceLeasesCurrent": 0, "tb6.DeferredRevenueAndDepositsCurrent": -6782562, "tb6.AccruedTaxLiabilities": 0, "tb6.DeferredTaxLiabilitiesCurrent": 0, "tb6.CommercialPapers": 0, "tb6.ShortTermBorrowings": 0, "tb6.OtherCurrentLiabilities": 0, "tb6.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb6.DividendsPayable": 0, "tb6.ShortTermPortionOfLongTermDebt": 0, "tb6.LongTermDebt": -868947, "tb6.PreferredSharesLiability": 0, "tb6.RetirementBenefits": 0, "tb6.OperatingLeasesNonCurrent": 0, "tb6.FinanceLeasesNonCurrent": 0, "tb6.LeaseIncentiveObligation": 0, "tb6.DeferredRevenueAndDepositsNonCurrent": -10869218, "tb6.ContingentConsideration": 0, "tb6.AccruedTaxLiabilitiesNonCurrent": 0, "tb6.DeferredTaxLiabilitiesNonCurrent": 0, "tb6.OtherNonCurrentLiabilities": -4600000, "tb6.RedeemableNonControllingInterests": 0, "tb6.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb6.ConvertibleDebtBeginning": 0, "tb6.CommonSharesBeginning": 408905, "tb6.CommonSharesIssued": -408905, "tb6.ShareBasedCompensation": 0, "tb6.PreferredSharesBeginning": 0, "tb6.RetainedEarningsBeginning": 33575334, "tb6.DividendsAndDividendEquivalentsDeclared": 0, "tb6.CommonSharesRepurchasedAndRetired": 0, "tb6.ShareBasedCompensationRetainedEarnings": 0, "tb6.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb6.RetainedEarningsOthers": 0, "tb6.AccumulatedOtherComprehensiveIncomeBeginning": 0, "tb6.TreasurySharesBeginning": 0, "tb6.PurchaseAndSellOfTreasuryShares": 0, "tb6.EmployeeBenefitTrustBeginning": 0, "tb6.NonControllingInterestsBeginning": 0, "tb6.DividendsDeclaredToNonControllingInterests": 0, "tb6.AcquisitionOfNonControllingInterests": 0, "tb6.NonControllingInterestsOthers": 0, "tb6.Sales": -21091431, "tb6.CostOfSales": 5630865, "tb6.ResearchAndDevelopment": 45780, "tb6.SellingGeneralAdministrativeAndMarketing": 12481562, "tb6.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb6.NonOperatingIncome": 1983703, "tb6.IncomeTaxExpenseBenefit": -7156822, "tb6.EquityMethodInvesteesIncome": 0, "tb6.NetIncomeFromDiscontinuedOperations": 0, "tb6.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb6.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb6.ChangeInUnrealizedGainsLossesOnInvestments": -169932, "tb6.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.IncomeTaxOnOtherComprehensiveIncome": 0}]}